Amprion Announces Strategic Growth Initiatives, Expanding Access to Breakthrough SAAmplify Test
Following its recent collaboration with Mayo Clinic Laboratories, Amprion launched a newly redesigned website to meet the growing demand for its SAAmplify-ɑSYN test, which aids in the diagnosis of synucleinopathies. The breakthrough test can detect the presence of aggregates of alpha-synuclein protein, the underlying pathology of Parkinson's disease (PD), Lewy body dementia (LBD), multiple system atrophy (MSA), and Alzheimer's disease with Lewy bodies (AD + DLB), in cerebrospinal fluid. Launched earlier this month, the updated website is designed to provide patients, clinicians, and industry leaders with streamlined access to Amprion's latest research, information, and more.
'As awareness and demand for our SAAmplify-ɑSYN test grow, we're working to ensure clinicians, researchers, and patients have better access to the tools and information they need,' said Dr. Russ Lebovitz, CEO and co-founder of Amprion. 'Our refreshed website and expanding partnerships are steps toward that goal, and we look forward to connecting with the global neuroscience community at AAIC.'
Due to this surge in awareness, Amprion is actively exploring international expansion opportunities, with plans to bring its test to European and global markets. Initial announcements regarding country-specific launch strategies are expected in Q4 2025.
For more information or to schedule a meeting with Amprion at AAIC 2025, please visit www.ampriondx.com.
About SAAmplify-ɑSYN (formerly SYNTap®)
Amprion's SAAmplify-ɑSYN test is a first-in-class-qualitative Laboratory Developed Test (LDT) and the only seed amplification assay available to aid the diagnosis of synucleinopathies such as Parkinson's disease (PD), Lewy body dementia (LBD/DLB), and Alzheimer's disease (AD) with Lewy body co-pathology. The U.S. Food and Drug Administration (FDA) granted Amprion a Breakthrough Device Designation in 2019 for use of the test as an aid in the diagnosis of PD. The test became commercially available in the US in 2021.
About Amprion
Amprion is the global leader advancing diagnosis of neurodegenerative disorders through seed amplification testing. Amprion's intellectual property surrounding SAA methodology extends to research, drug development, and commercialization. SAAmplify-ɑSYN (formerly SYNTap®) is the only seed amplification assay available to aid the diagnosis of synucleinopathies such as Parkinson's disease, Lewy body dementia, and Alzheimer's disease with Lewy body co-pathology. Amprion is also accelerating precision medicine for neurodegenerative disorders by helping biopharma partners identify new drug candidates and underlying pathologies. Learn more at https://ampriondx.com/ or find us on LinkedIn.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
4 hours ago
- Associated Press
T-NeuroDx to Present Advances in Blood Test for Early Alzheimer's Detection at Major Conference
'We believe that studying the body's adaptive immune system will play a pivotal role in the early detection of Alzheimer's'— Dr. Wheeler ALBUQUERQUE, NM, UNITED STATES, July 27, 2025 / / -- T-NeuroDx, a company pioneering new diagnostic tools that use abnormalities in the immune system to detect Alzheimer's Disease, will present its latest research at the 2025 Alzheimer's Association International Conference (AAIC) in Toronto, Canada, from July 27–31. Dr. Christopher Wheeler, the company's Chief Science Officer, will share new findings about the company's promising blood test for Alzheimer's. The research focuses on identifying specific aged immune cells in the blood that act as an early warning sign, or 'biomarker,' for the disease. A significant breakthrough in this new study is the enhancement of the test to be effective for all Alzheimer's patients, a critical step toward making this technology widely available. This builds upon Dr. Wheeler's initial discovery of the biomarker announced last year . 'We believe that studying the body's adaptive immune system will play a pivotal role in the early detection of Alzheimer's,' said Dr. Wheeler. 'Our results strengthen our case for a scalable, blood-based diagnostic that can move us closer to timely intervention and improved outcomes.' T-NeuroDx's vision is to create simple, accessible blood tests that can help doctors diagnose Alzheimer's sooner, allowing for earlier treatment and better patient care. Presentation Details: • Poster Title: #107315 - Levels of age-related blood CD8 T cells binding a non-self peptide/HLA epitope track with Alzheimer's disease status in HLA-A2+ and HLA-A2- cohorts: a T cell biomarker assay applicable to all patients. • Session: Biomarkers (non-neuroimaging) track. • Event: Alzheimer's Association International Conference (AAIC) 2025 • Date: Monday, July 28, 2025 • Time: 7:30 AM – 4:15 PM EDT • Location: Toronto, Canada For more information about T-NeuroDx, please visit John Chavez T-NeuroDx +1 505-660-1046 [email protected] Legal Disclaimer: EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
New York Post
5 hours ago
- New York Post
Grow up in the ‘60s or ‘70s? This ‘dangerously high' exposure may have put your brain at risk
Prepare to fume. Leaded gasoline was widely used as car fuel in the US from the 1920s until the 1970s — it was phased out because it was found to be harmful to the environment and human health. It's taken decades for the extent of lead's toxicity to be fully understood. A new study adds to the grim news — if you lived in an area with high levels of atmospheric lead between 1960 and 1974, when leaded gas was at its peak, you're 20% more likely to suffer memory problems later in life. 4 This photo shows cars lining up at a California gas station on Sep. 21, 1973, during peak use of leaded fuel. AP 'Research suggests half the US population — more than 170 million people — were exposed to high lead levels in early childhood,' said Maria C. Carrillo, the Alzheimer's Association's chief science officer and medical affairs lead. 'This research sheds more light on the toxicity of lead related to brain health in older adults today.' Lead was initially added to gas in the early 1920s to improve engine performance and prevent a knocking or rattling sound that occurs when fuel burns unevenly in the engine's cylinders. It was eventually deemed dangerous to the maturing brains and nervous systems of young children, who experienced developmental, learning and behavioral difficulties. 4 Leaded gas was slowly phased out in the US for on-road vehicles before being banned in 1996. This photo is of an NYC gas station circa 1980. Getty Images Adults faced neurological and reproductive issues, and soil and water contamination persisted. The sale of leaded fuel for on-road vehicles was gradually reduced in the US over two decades, with a full ban taking effect in 1996. For the new study, University of Toronto researchers mapped historic atmospheric lead levels in the US. They compared this data to the memory difficulties that more than 600,000 residents 65 and over described from 2012 to 2021. Residents were only included in the analysis if they lived in their birth state. The study authors calculated that 17% to 22% of people in places with moderate, high or extremely high atmospheric lead levels reported memory problems. 'When I was a child in 1976, our blood carried 15 times more lead than children's blood today,' said Esme Fuller-Thomson, senior author of the study and director of the Institute for Life Course and Aging at the University of Toronto. 'An astonishing 88% of us had levels higher than 10 micrograms per deciliter, which are now considered dangerously high.' 4 A new study suggests that if you lived in an area with high levels of atmospheric lead between 1960 and 1974, when leaded gas was at its peak, you're 20% more likely to suffer memory problems later in life. wirojsid – The researchers — who are presenting their work this week at the Alzheimer's Association International Conference (AAIC) in Toronto — recommend that those concerned about decades-old lead exposure focus on reducing other dementia risk factors, such as high blood pressure, smoking and loneliness. Over 6 million Americans have dementia, which gradually destroys memory, concentration and judgment skills. It's responsible for more than 100,000 deaths each year. Unfortunately, there's no easy way to measure long-term lead exposure. Lead levels in the blood primarily reflect recent or ongoing exposure. Lead is stored in the bones for significantly longer than in the blood — but that marker presents challenges. 'Some research studies have measured lead in the bone,' Dr. Eric Brown, lead study author, told The Post. 'This is done by using a technology called K-X-ray fluorescence, however, it is not available to the general public and is primarily a research tool, not a clinical tool.' What's more, leaded gas is still used in some aircraft and race cars — and lead pipes and paint remain a significant public health concern in many areas. 4 This photo from June 2020 shows lead paint chipping off a wall in Clifton, NJ. Christopher Sadowski A separate study shared at AAIC revealed that lead exposure — even at low levels — can contribute to the accumulation of abnormal tau and amyloid beta, proteins associated with Alzheimer's disease, in brain cells. And finally, another AAIC study found that older adults living about 3 miles from a lead-releasing facility — such as glass, ready-mixed concrete or computer and electronics manufacturers — face greater odds of memory and thinking problems than those living farther away. 'Our results indicate that lead exposure in adulthood could contribute to worse cognitive performance within a few years,' said Kathryn Conlon, senior study author and an associate professor of environmental epidemiology at UC Davis. 'Despite tremendous progress on lead abatement,' she added, 'studies have shown there is no safe level of exposure, and half of US children have detectable levels of lead in their blood.'
Business Wire
13 hours ago
- Business Wire
100 Days to 8th CIIE: Preps Harden as Global Exhibitors Eye Business Potential in China
SHANGHAI--(BUSINESS WIRE)--Facing the complex international landscape and mounting challenges, China International Import Expo (CIIE) consistently acts as a platform for global business exchange. With only 100 days to go, the 8th CIIE is set to take place in Shanghai from November 5 to 10. As of now, over 50 countries and international organizations have confirmed their participation in the Country Pavilion. Sweden and the United Arab Emirates will serve as guest countries of honor at the 8th CIIE, while Kyrgyzstan will make its debut. To help global enterprises across sectors better integrate into the Chinese market, the Corporate Pavilion features six major exhibition areas—encompassing Medical Equipment and Healthcare Products, Automobile and Smart Mobility, Intelligent Industry & Information Technology, Consumer Goods, Food and Agriculture Products, and Trade in Services—and will continue hosting its Innovation Incubation Special Section. Driven by strong interest and participation from overseas companies, total booked exhibition space has surpassed 330,000 square meters, with 170 companies and 26 institutions becoming eight-time full-attendance exhibitors. Notably, this year's Corporate Pavilion introduces four fresh innovations, demonstrating its vibrant energy and vast collaboration opportunities for participants. A special section for the least-developed countries products will launch alongside an upgraded Africa products section, helping 53 diplomatic African partners leverage zero-tariff treatment to enter the Chinese market. A new section for overseas provinces and cities stands as another highlight. Focused on global premieres, a dedicated trail for exploring debuts and a section amplifying exhibitors' presence are introduced. A cross-border e-commerce platform will be established for specialized promotion, matching, and livestreaming. The 8th Hongqiao International Economic Forum (HQF) will convene under the theme 'Opening-up for New Opportunities, Cooperation for a Shared Future.' Alongside the release of the World Openness Report 2025 and the latest World Openness Index, the HQF will host over 20 parallel sessions on revitalizing multilateral cooperation, empowering digital intelligence, green and sustainable development, and a more open China. Side events will retain previous categories, while people-to-people exchange activities will add a new 'Charming Friends of City' zone, inviting international friendly provinces and cities to set up their booths. Stay tuned for the 8th CIIE – secure your spot now! Sign up as an exhibitor: Sign up as a professional visitor:
